Yale Cancer Center

This afternoon starting at 3:15pm PDT/6:15pm EDT, we have five poster presentations at #AAPMCOMP26 featuring Dr. Yiu-Hsin Chang; Dr. Huixiao Chen; Yuchen Jessie Jiang; Dr. Sameer Taneja; and Xinran Li! aapm.confex.com/aapm/2026am/me… @YaleRadOnc @DaveJCarlson

Dr. Allison Shields @YaleRadiology is moderating a session this afternoon at #AAPMCOMP26 on Spectral CT imaging. aapm.confex.com/aapm/2026am/me… @SmilowCancer @DaveJCarlson

Tonight on Yale Cancer Answers, Dr. Mandar Muzumdar @MuzumdarLab discusses the dramatic rise in #pancreaticcancer and how his lab is studying whether the types of fats we consume may contribute to the development of #cancer, including pancreatic cancer. 🎧Listen live @wnpr 🔁Download @ApplePodcasts 💻Listen later @YouTube @SmilowCancer @YaleGICancers

Dr. Huixiao Chen is presenting this morning at #AAPMCOMP26 in Room 109 on "Clinical Physics Experience with CRAD SGRT for Multi-Tumor-Site Patient Setup and  Intrafraction Motion Monitoring." aapm.confex.com/aapm/2026am/me… @SmilowCancer @YaleRadOnc @DaveJCarlson

Congratulations to Drs. Yiu-Hsin Chang; Dae Yup Han; and Sameer Taneja for their research being selected for digital poster viewing at #AAPMCOMP26. aapm.confex.com/aapm/2026am/me… @SmilowCancer @YaleRadOnc @DaveJCarlson

We're proud that faculty and researchers from our #RadiationOncology team will be participating and contributing their expertise at AAPM | COMP Annual Meeting & Exhibition this weekend! aapm.confex.com/aapm/2026am/me… @SmilowCancer @YaleRadOnc @DaveJCarlson

Dr. Cary Gross @cpgYALE discusses financial conflicts of interest across #cancercare and research, along with his recent @JNCI_Now study highlighting the prevalence of industry ties throughout the US cancer ecosystem. medicine.yale.edu/cancer/news-ar… @SmilowCancer @YaleCOPPER

Dr. Francine Foss @YaleHematology, director of the @YaleCancer T-cell Lymphoma Program + co-chair of #TCLF, discusses recent advances in peripheral T-cell lymphoma therapy, including novel treatment pathways + targetable mutations. youtu.be/OxylKmt8vzI?si… @SmilowCancer @mghpetal

.@IraLeeds_MD received a @DeptVetAffairs Career Development Award to study to how psychosocial risk factors contribute to complications following major #cancer surgery among #Veterans. medicine.yale.edu/cancer/news-ar… @SmilowCancer @YaleGICancers

Congratulations to @AmosEspinosa1 of @Krauselab_Yale, recipient of the Ruth L. Kirschstein NRSA for Individual Predoctoral Fellows #F31 Award from @theNCI! This award will support his research into megakaryoblastic #leukemia. medicine.yale.edu/cancer/news-ar… @SmilowCancer @yalepathology

In his latest editor's letter, @Dr_AmerZeidan, of @YaleCancer, reflects on the shifting chemotherapy landscape for patients with #AML. 📰 Read here! buff.ly/HCyPDAc

New research from Dr. Michaela Dinan @YaleSPH  suggests benefits of 3D breast imaging #DBT may differ by age. In women 67–74, it was associated with detection of smaller, lower-grade tumors. For women 75+, benefits were limited, highlighting a need for individualized screening decisions. medicine.yale.edu/cancer/publica… @SmilowCancer @YaleBreast @ClinMedJournals

A study led by @JayBader_MD + @kturaga highlights the importance of genetic testing in #PleuralMesothelioma to improve prognostication and guide enrollment in #ClinicalTrials for targeted therapies. In contrast, genetic mutations had less prognostic impact in #peritonealmesothelioma. medicine.yale.edu/cancer/publica… @SmilowCancer @YaleGICancers @Nature_NPJ

Fantastic Medical Crossfire Meeting on Hematologic Malignancies @gotoPER #MXH26 in NYC July 2026, with great participation from our @Yale University @YaleCancer @YaleHematology group with 7 faculty & fellow participants. Mark your calendars for July 17-18, 2027 edition

Dr. Benjamin Judson @YaleSurgery joins #YaleCancerAnswers tonight to share his expertise in surgery for #headandneckcancer, including advances in reconstructive, robotic, and minimally invasive surgical techniques. 🎧Listen live @wnpr 🔁Download on @ApplePodcasts 💻Listen later @YouTube @SmilowCancer @Yale_ENT

Congratulations to Dr. Mohammed Ali named the 2026 recipient of the JH Milstone Award, presented annually to support early-stage investigators and innovative research that improves understanding of bleeding, thrombosis, or thrombolysis. medicine.yale.edu/cancer/news-ar… @SmilowCancer @YaleHematology @YaleHemOnc

In this Q&A with @YaleSOM, @cececalhounMD explains why improving care for people with #SickleCellDisease requires more than medical expertise. She reflects on the challenges of building teams & systems to support patients facing both chronic illness and systemic inequities. insights.som.yale.edu/insights/mobil… @SmilowCancer @YaleHematology

How do you select high-risk HR+/HER2- early breast cancer patients for adjuvant CDK4/6 inhibitor therapy when they don't fit neatly into monarchE or NATALEE criteria? Ruta Rao, MD and Eric Winer, MD break down real-world decision-making. Watch the full OncLive® Insights series: hubs.li/Q04nQkNQ0 @RutaRaoMD @DrEricWiner @YaleCancer @SmilowCancer #BreastCancer #CDK46Inhibitors #HRPositiveBreastCancer

A new Yale-led study published in @JNCI_Now #CancerSpectrum found that #Veterans living in neighborhoods with higher incomes and education levels had slightly increased risk of #pancreaticcancer. medicine.yale.edu/cancer/news-ar… @SmilowCancer @YaleDigestive

Congratulations to the @YaleRadOnc #RefleXion team who was awarded an Academic Industry Partnership (AIP) #R01 Grant from the @NIH for their project: "Development and Clinical Translation of Advanced PET Imaging for Real-Time Biology-Guided Radiotherapy.” @SmilowCancer @YaleRadiology